STAT3 and hematologic disorder: The clinical relevance of hyperactive STAT3 has been linked to subsets of hematological malignancies, with the identification of JAK1/3 or STAT3 mutations (Jerez et al., 2012; Koskela et al., 2012; Crescenzo et al., 2015; Milner et al., 2015).